A randomised controlled phase 3 study of oral pacritinib versus best available therapy in patients with primary myelofibrosis post polycthemia vera myelofibrosis or post essential
- Coughlin, Paul (Primary Chief Investigator (PCI))
Project: Research
Project: Research